|
AMOTL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.30000521037755E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.64210003769949E-09 |
| Normal-vs-Stage2 |
2.39350000041938E-07 |
| Normal-vs-Stage3 |
1.85690000042982E-07 |
| Normal-vs-Stage4 |
4.97270002952632E-10 |
| Stage1-vs-Stage2 |
6.174600E-01 |
| Stage1-vs-Stage3 |
7.313400E-01 |
| Stage1-vs-Stage4 |
3.038000E-02 |
| Stage2-vs-Stage3 |
8.205200E-01 |
| Stage2-vs-Stage4 |
2.099800E-01 |
| Stage3-vs-Stage4 |
1.186370E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.58210003273507E-09 |
| Normal-vs-AfricanAmerican |
4.657300E-03 |
| Normal-vs-Asian |
6.14580000000142E-05 |
| Caucasian-vs-AfricanAmerican |
5.220200E-01 |
| Caucasian-vs-Asian |
6.416000E-01 |
| AfricanAmerican-vs-Asian |
8.063200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.83360026951141E-11 |
| Normal-vs-Female |
2.4816000365746E-09 |
| Male-vs-Female |
7.754500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.44930000024158E-07 |
| Normal-vs-Age(41-60Yrs) |
3.17589954335062E-10 |
| Normal-vs-Age(61-80Yrs) |
8.95483687202159E-12 |
| Normal-vs-Age(81-100Yrs) |
4.976600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.768010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.655200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.381200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.379900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.125800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.027000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.157000E-01 |
| Classical-VS-Follicular |
7.72540000000266E-05 |
| Classical-VS-Other |
4.470400E-02 |
| Classical-VS-Normal |
1.0385000004387E-07 |
| Tall-VS-Follicular |
7.756000E-02 |
| Tall-VS-Other |
1.509980E-01 |
| Tall-VS-Normal |
1.957860E-04 |
| Follicular-VS-Other |
4.232000E-01 |
| Follicular-VS-Normal |
1.99151806157261E-12 |
| Other-VS-Normal |
1.354430E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12041495473159E-12 |
| Normal-vs-N1 |
7.54680000047969E-07 |
| N0-vs-N1 |
8.970200E-01 |
|
|
